Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Dec;310(1):59-67.
doi: 10.1007/BF00499875.

Specific binding of 3H-adenosine to rat brain membranes

Specific binding of 3H-adenosine to rat brain membranes

U Schwabe et al. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec.

Abstract

The binding of 3H-adenosine to rat brain membranes was studied by a microcentrifugation technique. Specific binding of 3H-adenosine was rapid, reversible, saturable and dependent on pH and temperature. Scatchard plots of equilibrium binding data were nonlinear suggesting the existence of two different binding sites for adenosine. The dissociation constants (Kd) were 1.7 muM and 13.6 muM and the maximal number of binding sites (Bmax) 31 and 165 pmol adenosine bound per mg of membrane protein. Ten adenosine derivatives were studied for their ability to compete with 3H-adenosine binding. The phosphorylated adenosine compounds 5'-AMP, cyclic AMP and ATP were most potent in displacing 3H-adenosine from its binding sites and the IC50-values ranged from 11--25 muM. N6-Phenylisopropyladenosine produced only partial inhibition (30%) of 3H-adenosine binding and no stereospecific difference between the (-)- and (+)isomer was observed. Several methylxanthines known as adenosine antagonists competed for the 3H-adenosine binding sites parallel with their pharmacological potency. The results offer a first approach for the study of adenosine binding sites in brain membranes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Adv Biochem Psychopharmacol. 1970;3:113-33 - PubMed
    1. Pharmacology. 1977;15(1):84-9 - PubMed
    1. Adv Cyclic Nucleotide Res. 1975;5:569-84 - PubMed
    1. Mol Pharmacol. 1975 Sep;11(5):528-44 - PubMed
    1. Mol Pharmacol. 1970 Jan;6(1):13-23 - PubMed